Pipeline of Migraine Market Reviewed for H2 2015

ReportsnReports adds Migraine market research to its database.

This report provides comprehensive information on the therapeutic development for Migraine, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Migraine and special features on late-stage and discontinued projects.

Inquire more about this research report at http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=459921 .

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Complete research report of 217 Pages is available at http://www.reportsnreports.com/reports/459921-migraine-pipeline-review-h2-2015.html .

Scope

• The report provides a snapshot of the global therapeutic landscape of Migraine
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Migraine and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Migraine products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Migraine pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Migraine
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Migraine pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

List of Figures

Number of Products under Development for Migraine, H2 2015 16
Number of Products under Development for Migraine – Comparative Analysis, H2 2015 17
Number of Products under Development by Companies, H2 2015 18
Number of Products under Investigation by Universities/Institutes, H2 2015 22
Comparative Analysis by Late Stage Development, H2 2015 23
Comparative Analysis by Clinical Stage Development, H2 2015 24
Comparative Analysis by Early Stage Products, H2 2015 25
Assessment by Monotherapy Products, H2 2015 71
Assessment by Combination Products, H2 2015 72
Number of Products by Top 10 Targets, H2 2015 73
Number of Products by Stage and Top 10 Targets, H2 2015 73
Number of Products by Top 10 Mechanism of Actions, H2 2015 77
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 77
Number of Products by Top 10 Routes of Administration, H2 2015 80
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 80
Number of Products by Top 10 Molecule Types, H2 2015 82
Number of Products by Stage and Top 10 Molecule Types, H2 2015 82